Literature DB >> 34003292

RE: Assessment of Ki67 in Breast Cancer: Updated Recommendations from the International Ki67 in Breast Cancer Working Group.

Jiandi Zhang1, Maozhou Yang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34003292      PMCID: PMC8562964          DOI: 10.1093/jnci/djab093

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Adding quality to your qualitative IHC.

Authors:  Lars Rudbeck
Journal:  MLO Med Lab Obs       Date:  2015-12

2.  Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.

Authors:  Todd Hembrough; Sheeno Thyparambil; Wei-Li Liao; Marlene M Darfler; Joseph Abdo; Kathleen M Bengali; Paul Taylor; Jiefei Tong; Humberto Lara-Guerra; Thomas K Waddell; Michael F Moran; Ming-Sound Tsao; David B Krizman; Jon Burrows
Journal:  Clin Proteomics       Date:  2012-05-03       Impact factor: 3.988

3.  Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method.

Authors:  Junmei Hao; Yan Lyu; Jiarui Zou; Yunyun Zhang; Shuishan Xie; Lili Jing; Fangrong Tang; Jiahong Lyu; Wenfeng Zhang; Jianbo Zhang; Xunting Wang; Kuisheng Chen; Jiandi Zhang
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

4.  Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.

Authors:  Samuel C Y Leung; Torsten O Nielsen; Lila Zabaglo; Indu Arun; Sunil S Badve; Anita L Bane; John M S Bartlett; Signe Borgquist; Martin C Chang; Andrew Dodson; Rebecca A Enos; Susan Fineberg; Cornelia M Focke; Dongxia Gao; Allen M Gown; Dorthe Grabau; Carolina Gutierrez; Judith C Hugh; Zuzana Kos; Anne-Vibeke Lænkholm; Ming-Gang Lin; Mauro G Mastropasqua; Takuya Moriya; Sharon Nofech-Mozes; C Kent Osborne; Frédérique M Penault-Llorca; Tammy Piper; Takashi Sakatani; Roberto Salgado; Jane Starczynski; Giuseppe Viale; Daniel F Hayes; Lisa M McShane; Mitch Dowsett
Journal:  NPJ Breast Cancer       Date:  2016-05-18

5.  Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment.

Authors:  E An; C-Y Ock; T-Y Kim; K-H Lee; S-W Han; S-A Im; T-Y Kim; W-L Liao; F Cecchi; A Blackler; S Thyparambil; W H Kim; J Burrows; T Hembrough; D V T Catenacci; D-Y Oh; Y-J Bang
Journal:  Ann Oncol       Date:  2017-01-01       Impact factor: 32.976

6.  Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.

Authors:  Torsten O Nielsen; Samuel C Y Leung; David L Rimm; Andrew Dodson; Balazs Acs; Sunil Badve; Carsten Denkert; Matthew J Ellis; Susan Fineberg; Margaret Flowers; Hans H Kreipe; Anne-Vibeke Laenkholm; Hongchao Pan; Frédérique M Penault-Llorca; Mei-Yin Polley; Roberto Salgado; Ian E Smith; Tomoharu Sugie; John M S Bartlett; Lisa M McShane; Mitch Dowsett; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2021-07-01       Impact factor: 13.506

  6 in total
  2 in total

1.  Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method.

Authors:  Junmei Hao; Yan Lyu; Jiarui Zou; Yunyun Zhang; Shuishan Xie; Lili Jing; Fangrong Tang; Jiahong Lyu; Wenfeng Zhang; Jianbo Zhang; Xunting Wang; Kuisheng Chen; Jiandi Zhang
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

2.  Validation of absolutely quantitated Ki67 and cyclinD1 protein levels for prognosis of Luminal-like breast cancer patients.

Authors:  Guohua Yu; Jiahong Lyu; Yalun Li; Yunyun Zhang; Yan Lyu; Wengfeng Zhang; Jianbo Zhang; Bocheng Cai; Jiandi Zhang; Fangrong Tang
Journal:  J Clin Lab Anal       Date:  2022-07-12       Impact factor: 3.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.